SingHealth
Increase Font Size Decrease Font Size
Print Page Email Friend

Clinical Trials

A clinical trial is any investigation in human subjects intended to discover or verify the clinical, pharmacological and/ or other pharmacodynamic effects of an investigational product(s) such as drug, vaccine or medical device with the objective of determining its safety and efficacy.

All clinical trials in Singapore must be reviewed and approved by an Ethics Committee and the Health Sciences Authority. The oversight by the ethics and regulatory bodies ensures that research is carried out in a safe and ethical manner.

Research studies in KKH test new drugs, devices, therapies and treatments in the following areas:

Division of Obstetrics & Gynaecology

  • Assisted reproductive technology
  • Gynaecological cancers
  • Improvement on pregnancy outcome
  • Management of labor-related pain
  • Prevention of post-operative nausea and vomiting
  • Prevention of pre-term births
  • Urogynaecology

Division of Clinical Support Services

  • Anaesthesia
  • Diagnostic and Interventional Imaging

Division of Paediatrics Medicine

  • Allergy and immunology
  • Cardiovascular diseases
  • Child development
  • Diabetes
  • Digestive diseases
  • Emergency medicine
  • Genetics
  • Haematology disorders
  • Infectious diseases
  • Kidney diseases
  • Management of ICU patients
  • Mental wellness
  • Neurological diseases
  • Nutrition
  • Neurological diseases
  • Paediatrics cancer
  • Pulmonary diseases
  • TCM as alternative medicine

Division of Surgery

  • Neurosurgery
  • Plastic, Reconstructive & Aesthetic surgery

There are many different ways to participate in clinical trials at KK Women’s and Children’s Hospital. Volunteers may be healthy, at risk for developing a disease, or already diagnosed with a disease or illness. You can agree to be in a trial, give permission to have your medical record reviewed for research, or you can give permission for use of your blood and tissue samples.


On-going Clinical Trials at KKH:

Women's Ovary Cancer treatment
Contact person: Ms Louise Wong Poi Yan at 97858811 or 63948241 and also Ms Liu Juan at 63943791

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Weekly Farletuzumab (MORAb-003 ) in Combination with Carboplation and Taxane in Subjects with Platinum-sensitive Ovarian Cancer in First Relapse. - SHORT FORM: MORAb-003 Study It is clinical trial to test a new anti-cancer drug named Farletuzumab for ovarian cancer patients with disease progression aged 18 years and above.

READ MORE

Find A Doctor
Book An Appointment
Admission And Charges
Events
Health X-Change
Quick Links